院外心脏骤停复苏后接受治疗性低温的幸存者初始血糖下降速率与神经功能结局的关系
该单中心回顾性队列纳入2007年4月至2011年12月接受治疗性低温的145例成人非创伤性院外心脏骤停幸存者,按6个月时脑功能分级(CPC)分为良好组(CPC1-2)与不良组(CPC3-5),计算血糖变化速率。良好组达到目标血糖所需时间更短(7.4 vs 13.17 h,p<0.001),平均血糖下降速率更快(17.06 vs 8.33 mg/dl/h,p=0.005)。多因素分析中,更快的下降速率(OR 1.074,95%CI 1.029-1.12,p=0.001)和更短的达标时间(OR 13.888,95%CI 2.271-84.906,p=0.004)与良好神经功能结局独立相关。作者结论认为二者与良好结局相关,但最佳血糖控制策略尚未确定。
要点
- 良好神经功能结局组达到目标血糖时间更短:7.4(2.97-18.13)h vs 13.17(7.55-27.0)h,p<0.001。
- 良好结局组平均血糖下降速率更快:17.06(6.67-34.49)mg/dl/h vs 8.33(4.26-18.55)mg/dl/h,p=0.005。
- 多因素分析:血糖下降速率更快与良好结局独立相关(OR 1.074,95%CI 1.029-1.12,p=0.001)。
- 多因素分析:达到目标血糖时间更短与良好结局独立相关(OR 13.888,95%CI 2.271-84.906,p=0.004)。
- 作者结论:初始血糖下降更快和达标时间更短与良好神经功能结局相关,但改善结局的最佳血糖控制策略仍未确定。
适用人群与场景
- 成人非创伤性院外心脏骤停幸存者,接受治疗性低温,2007年4月至2011年12月单中心纳入,共145例。
- 按院外心脏骤停后6个月脑功能分级(CPC)分为良好组(CPC1和CPC2)与不良组(CPC3-CPC5)。
诊断标准与关键阈值
- 神经功能结局评估:院外心脏骤停后6个月脑功能分级(CPC),CPC1-2为良好结局,CPC3-5为不良结局。
研究设计与关键结果
- 研究类型:单中心回顾性队列研究,样本量145例成人非创伤性院外心脏骤停幸存者,均接受治疗性低温。
- 主要终点:6个月脑功能分级(CPC)良好(CPC1-2)与不良(CPC3-5)。
- 良好组达到目标血糖时间7.4(2.97-18.13)h vs 不良组13.17(7.55-27.0)h,p<0.001。
- 良好组平均血糖下降速率17.06(6.67-34.49)mg/dl/h vs 不良组8.33(4.26-18.55)mg/dl/h,p=0.005。
- 多因素分析:血糖下降速率更快与良好结局独立相关(OR 1.074,95%CI 1.029-1.12,p=0.001)。
- 多因素分析:达到目标血糖时间更短与良好结局独立相关(OR 13.888,95%CI 2.271-84.906,p=0.004)。
证据类型、等级与局限
- 证据类型:单中心回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者结论认为,在院外心脏骤停后接受治疗性低温的幸存者中,初始血糖下降更快和达标时间更短与良好神经功能结局相关,但改善结局的最佳血糖控制策略仍未确定,原文未据此给出具体血糖管理推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Hyperglycemia in out-of-hospital cardiac arrest (OHCA) survivors is associated with poor outcomes. However, in the control of initial hyperglycemia, an adequate strategy to improve patients' neurologic outcomes remains undetermined. Prior to the establishment of such strategy, we need to determine whether a decreased rate of initial blood glucose (BG) affects patient outcomes.
METHODS: One hundred and forty-five adult non-traumatic OHCA survivors treated with therapeutic hypothermia between April 2007 and December 2011 were enrolled in this single-center retrospective cohort study. Based on the cerebral performance category (CPC) at 6 months after OHCA, study populations were categorized as "Good CPC group" (favorable outcome, CPC1 and CPC2) and "Poor CPC group" (unfavorable outcome, CPC3-CPC5). Variables related to BG were obtained, and the rate of BG change was calculated.
RESULTS: In the Good CPC group, the time required to attain target BG levels was shorter [7.4 (2.97-18.13) vs. 13.17 (7.55-27.0) h, p < 0.001], and the average rate of glucose decrease until the attainment of target BG levels was faster [17.06 (6.67-34.49) vs. 8.33 (4.26-18.55) mg/dl/h, p = 0.005] than in the Poor CPC group. Using multivariate analysis, the faster rate (odds ratio 1.074; 95% confidence interval 1.029-1.12; p = 0.001) and the shorter time (odds ratio 13.888; 95% confidence interval 2.271-84.906; p = 0.004) required to attain target BG levels were independently related to favorable neurologic outcomes.
CONCLUSIONS: Faster rates of initial BG decrease and the shorter time required to attain target BG levels were associated with favorable neurologic outcome in survivors of OHCA receiving therapeutic hypothermia.
参考来源
- Woo JH, Lim YS, Yang HJ, et al. The Relationship Between the Decreased Rate of Initial Blood Glucose and Neurologic Outcomes in Survivors of Out-of-Hospital Cardiac Arrest Receiving Therapeutic Hypothermia. Neurocrit Care. 2017. PMID: 28004333. doi:10.1007/s12028-016-0353-8
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。